meperidine has been researched along with colforsin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chik, CL; Ho, AK; Negishi, T | 1 |
Bertaccini, E; Clark, DJ; Davies, MF; Krause, TK; Maze, M; Takada, K; Tonner, PH | 1 |
2 other study(ies) available for meperidine and colforsin
Article | Year |
---|---|
Ceramide enhances growth hormone (GH)-releasing hormone-stimulated cyclic adenosine 3',5'-monophosphate accumulation but inhibits GH release in rat anterior pituitary cells.
Topics: 1-Methyl-3-isobutylxanthine; 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Agonists; Ceramides; Colforsin; Cyclic AMP; Glucosyltransferases; Growth Hormone; Growth Hormone-Releasing Hormone; Ionomycin; Ionophores; Male; Meperidine; Pituitary Gland, Anterior; Potassium Chloride; Rats; Rats, Sprague-Dawley | 1999 |
Meperidine exerts agonist activity at the alpha(2B)-adrenoceptor subtype.
Topics: Adenylyl Cyclase Inhibitors; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Animals; Body Temperature Regulation; Colforsin; Male; Meperidine; Mice; Mice, Inbred C57BL; Naloxone; Receptors, Adrenergic, alpha-2; Shivering; Structure-Activity Relationship | 2002 |